• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用磷霉素治疗的外科化脓性感染和腹部外科感染。

Surgical suppurating infections and surgical abdominal infections treated with fosfomycin.

作者信息

Gallardo A, Sáez J M, Enriquez G, Cobacho A R, Torronteras R, Recordan C, Del Moral A, Arroyo A, Curiel A G

出版信息

Chemotherapy. 1977;23 Suppl 1:392-8. doi: 10.1159/000222080.

DOI:10.1159/000222080
PMID:832540
Abstract

Two groups of patients suffering surgical infections were treated with fosfomycin. The first includes 21 suppurating dermic of soft underlying tissue lesions. The second group includes 29 surgical abdominal infections. The bacteriology of the first group was made up of gram-positive and gram-negative germs predominantly S. aureus and E. coli, all the isolated species appeared to be sensitive to fosfomycin. In the second group a gram-negative bacterial flora predominantly E. coli was obtained; with a sensitivity to this antibiotic of 90.5%. Surgical treatment accompanied the treatment with fosfomycin. In the first group, all the patients were cured with the oral administration of 2-6 g/day and in an average time less than that of the similar control group which did not receive the antibiotic. In the second group surgical treatment was necessary in 25 of the 29 patients and in all of them parenteral treatment was done with fosfomycin, preferably intramuscularly and in general the dosage was 4 g daily. All patients were cured except for one who was not operated on and who suffered from a fever of undetermined origin.

摘要

两组患有外科感染的患者接受了磷霉素治疗。第一组包括21例化脓性真皮及皮下软组织病变患者。第二组包括29例外科腹部感染患者。第一组的细菌学检查发现主要为革兰氏阳性菌和革兰氏阴性菌,以金黄色葡萄球菌和大肠杆菌为主,所有分离出的菌种对磷霉素均敏感。第二组获得了以大肠杆菌为主的革兰氏阴性菌菌群,对该抗生素的敏感性为90.5%。在使用磷霉素治疗的同时进行了外科治疗。在第一组中,所有患者口服每日2 - 6克磷霉素均治愈,且平均治愈时间短于未接受抗生素治疗的类似对照组。在第二组的29例患者中,有25例需要进行外科治疗,所有这些患者均采用磷霉素进行非肠道给药治疗,最好是肌肉注射,一般剂量为每日4克。除1例未接受手术且患有不明原因发热的患者外,所有患者均治愈。

相似文献

1
Surgical suppurating infections and surgical abdominal infections treated with fosfomycin.用磷霉素治疗的外科化脓性感染和腹部外科感染。
Chemotherapy. 1977;23 Suppl 1:392-8. doi: 10.1159/000222080.
2
Activity of fosfomycin in the treatment of bacterial infections.
Chemotherapy. 1977;23 Suppl 1:358-64. doi: 10.1159/000222076.
3
Fosfomycin in infantile acute gastroenteritis.
Chemotherapy. 1977;23 Suppl 1:304-9. doi: 10.1159/000222067.
4
Fosfomycin in a traumatological department.创伤科中的磷霉素
Chemotherapy. 1977;23 Suppl 1:403-10. doi: 10.1159/000222082.
5
[Clinical experience with fosfomycin sodium for infectious diseases in obstetrics and gynecology].磷霉素钠在妇产科传染病中的临床应用经验
Jpn J Antibiot. 1983 Aug;36(8):2115-9.
6
Fosfomycin in the treatment of gynecological infections.磷霉素治疗妇科感染
Chemotherapy. 1977;23 Suppl 1:287-92. doi: 10.1159/000222062.
7
Treatment of respiratory infections with fosfomycin.
Chemotherapy. 1977;23 Suppl 1:348-57. doi: 10.1159/000222075.
8
Fosfomycin in acute bronchopneumopathies.
Chemotherapy. 1977;23 Suppl 1:331-6. doi: 10.1159/000222071.
9
Fosfomycin in the treatment of bacterial infections: summary of clinical trials in Japan.磷霉素治疗细菌感染:日本临床试验综述
Chemotherapy. 1977;23 Suppl 1:234-46. doi: 10.1159/000222054.
10
Neurosurgical infection treated with fosfomycin and 6-methylprednisolone.用磷霉素和6-甲基泼尼松龙治疗神经外科感染。
Chemotherapy. 1977;23 Suppl 1:399-402. doi: 10.1159/000222081.

引用本文的文献

1
The Impact of Fosfomycin on Gram Negative Infections: A Comprehensive Review.磷霉素对革兰氏阴性菌感染的影响:一项全面综述。
Indian J Microbiol. 2024 Sep;64(3):846-858. doi: 10.1007/s12088-024-01293-8. Epub 2024 May 7.
2
Fosfomycin in infections caused by multidrug-resistant Gram-negative pathogens.磷霉素在多重耐药革兰氏阴性病原菌引起的感染中的应用
Rev Esp Quimioter. 2019 May;32 Suppl 1(Suppl 1):45-54.
3
Adverse Events Associated with Fosfomycin Use: Review of the Literature and Analyses of the FDA Adverse Event Reporting System Database.
磷霉素相关不良事件:文献回顾及 FDA 不良事件报告系统数据库分析。
Infect Dis Ther. 2015 Dec;4(4):433-58. doi: 10.1007/s40121-015-0092-8. Epub 2015 Oct 5.
4
Distribution and antimicrobial activity of fosfomycin in the interstitial fluid of human soft tissues.磷霉素在人体软组织间质液中的分布及抗菌活性
Antimicrob Agents Chemother. 2000 Oct;44(10):2728-32. doi: 10.1128/AAC.44.10.2728-2732.2000.